INAB Stock INAB is expected to report earnings to rise+22% to -17 cents per share on May 10

A.I.dvisor
at Tickeron.com
05/09/24
Loading...
INAB - IN8bio
IN8bio Earnings Graph
Q1'24
Est.
$-0.17
Q4'23
Missed
by $0.07
Q3'23
Beat
by $0.02
Q2'23
Est.
$-0.27
Q1'23
Beat
by $0.02
The last earnings report on December 31 showed earnings per share of -22 cents, missing the estimate of -15 cents. P/B Ratio (1.783) is normal, around the industry mean (10.384). P/E Ratio (0.000) is within average values for comparable stocks, (111.243). INAB's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.409). INAB has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.014). P/S Ratio (0.000) is also within normal values, averaging (219.521). With 49.58K shares outstanding, the current market capitalization sits at 44.46M.
View a ticker or compare two or three
INABDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
350 5th Avenue
Phone
+1 646 600-6438
Employees
31
Web
https://www.in8bio.com